Ceredex Value Advisors’s Colgate-Palmolive CL Stock Holding History

Ceredex Value Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-736,969	Closed	-$56.8M	–	155
2023 Q2	$56.8M	Sell	736,969 -632,566	-46%	-$49M	0.91%	42
2023 Q1	$103M	Buy	1,369,535 +568,967	+71%	+$42.3M	1.6%	12
2022 Q4	$63.1M	Sell	800,568 -200,219	-20%	-$15M	0.97%	41
2022 Q3	$70.3M	Buy	1,000,787 +151,418	+18%	+$11.9M	1.15%	30
2022 Q2	$68.1M	Buy	+849,369	New	+$66.4M	1.02%	34
2019 Q3	–	Sell	-2,756	Closed	-$198K	–	163
2019 Q2	$198K	Sell	2,756 -442,372	-99%	-$31.4M	﹤0.01%	161
2019 Q1	$30.5M	Sell	445,128 -757,426	-63%	-$48.9M	0.37%	88
2018 Q4	$71.6M	Buy	+1,202,554	New	+$75.2M	0.96%	41

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ceredex Value Advisors's CL Position: Q3 2023 in Review

Ceredex Value Advisors sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 736,969 shares — an estimated $56.8M sold.

Ceredex Value Advisors first reported a position in CL in Q4 2018 and held it in 8 quarters. The position peaked at $103M in Q1 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

Ceredex Value Advisors reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
Ceredex Value Advisors sold 736,969 Colgate-Palmolive shares in Q3 2023, an estimated $56.8M.
Ceredex Value Advisors first reported a position in Colgate-Palmolive in Q4 2018 and held it in 8 quarters.
Ceredex Value Advisors's Colgate-Palmolive position peaked at $103M in Q1 2023.
1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Ceredex Value Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.